Direct phosphorylation and stabilization of HIF-1α by PIM1 kinase drives angiogenesis in solid tumors
Open accessPublished version of a preprint
The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Angiogenesis is essential for the sustained growth of solid tumors. Hypoxia-inducible factor 1 (HIF-1) is a master regulator of angiogenesis and constitutive activation of HIF-1 is frequently observed in human cancers. Therefore, understanding the mechanisms governing the activation of HIF-1 is critical for successful therapeutic targeting of tumor angiogenesis. Herein, we establish a new regulatory mechanism responsible for the constitutive activation of HIF-1α in cancer, irrespective of oxygen tension. PIM1 kinase directly phosphorylates HIF-1α at threonine 455, a previously uncharacterized site within its oxygen-dependent degradation domain. This phosphorylation event disrupts the ability of prolyl hydroxylases to bind and hydroxylate HIF-1α, interrupting its canonical degradation pathway and promoting constitutive transcription of HIF-1 target genes. Moreover, phosphorylation of the analogous site in HIF-2α (S435) stabilizes the protein through the same mechanism, indicating post-translational modification within the oxygen-dependent degradation domain as a mechanism of regulating the HIF-α subunits. In vitro and in vivo models demonstrate that expression of PIM1 is sufficient to stabilize HIF-1α and HIF-2α in normoxia and stimulate angiogenesis in a HIF-1-dependent manner. CRISPR mutants of HIF-1α (Thr455D) promoted increased tumor growth, proliferation, and angiogenesis. Moreover, HIF-1α-T455D xenograft tumors were refractory to the anti-angiogenic and cytotoxic effects of PIM inhibitors. These data identify a new signaling axis responsible for hypoxia-independent activation of HIF-1 and expand our understanding of the tumorigenic role of PIM1 in solid tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, PIM1 kinase, a serine-threonine kinase that promotes tumorigenesis by impacting cell cycle progression, survival, and proliferation, directly activates HIF-1α and HIF-2α through phosphorylation, disruping HIF-α degradation [11].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [11]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Independently of hypoxia, HIFs can also become activated through the activation of oncogenes, or loss of tumor suppressor genes.”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 1×
“Angiogenesis is a hallmark of cancer that is required to sustain tumor survival and growth (Hanahan and Weinberg, 2011).”
BackgroundTumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187 · cited 2×
“INTRODUCTION Angiogenesis, or the branching of blood vessels, is a rate-limiting step in the development of solid tumors [1].”
BackgroundThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180 · cited 1×
“Hydroxylation causes the von Hippel-Lindau (VHL) tumor suppressor protein to recognize HIF-1α and recruit a ubiquitin-protein ligase complex that leads to the ubiquitination and rapid degradation of HIF-1α by the 26S proteasome (Maxwell et al., 1999).”
BackgroundTargeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Transplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549 · cited 1×
“In the presence of oxygen, cytoplasmic HIF-α subunits are rapidly hydroxylated on prolines 402 (Pro402) and 564 (Pro564), located within the oxygendependent degradation domain (ODDD), by prolyl hydroxylasedomain proteins (PHDs) 1–3 [3, 4].”
BackgroundHIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267 · cited 1×
“Nicolas Denko (OSU) and have been previously described [57].”
BackgroundHIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693
Delineation of prognostic biomarkers in prostate cancer
Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2001) · Nature · doi:10.1038/35090585 · Cited by 1,673 · cited 1×
“Pim1 expression is elevated in ~50% of human prostate cancer specimens, particularly in high Gleason grade and aggressive metastatic prostate cancer cases, highlighting its ability to enhance tumorigenesis (Chen et al., 2005; Dhanasekaran et al., 2001).”
Background
Cited by
ROS production by mitochondria: function or dysfunction?
Palma, F. R., Gantner, B. N., Sakiyama, M. J., Kayzuka, C., Shukla, S., Lacchini, R., Cunniff, B., & Bonini, M. G. (2024) · Oncogene · doi:10.1038/s41388-023-02907-z · Cited by 507
“These include apoptosis [74 – 76], anoikis resistance (also known as cell anchorage independence) [77], and the activation of cell migration/ escape functions [78, 79].”
Bai, R., Li, Y., Jian, L., Yang, Y., Zhao, L., & Wei, M. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01645-2 · Cited by 279
“[77], PIM1 kinase directly phosphorylated HIF-1α regardless of oxygen tension to prevent PHDs from binding to and hydroxylating HIF-1α, hence interrupting its degradation pathway.”
BackgroundHIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies
Zhao, Y., Xing, C., Deng, Y., Ye, C., & Peng, H. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.039 · Cited by 202
“Increased expression of PIM1 in vivo can trigger the expression of HIF-1a target genes (VEGF and HK2) by directly phosphorylating HIF-1a at threonine 455, thereby inducing angiogenesis; however, VEGF is notably deficient in HIF-1a-knockdown tumor tissues.(66) Prolactin II (SCG2) is markedly under-expressed in malignan…”
BackgroundHypoxia-Inducible Factor 1-Alpha (HIF-1α): An Essential Regulator in Cellular Metabolic Control
Basheeruddin, M., & Qausain, S. (2024) · Cureus · doi:10.7759/cureus.63852 · Cited by 95
“The stability and function of HIF-1 α are impacted when kinases in pathways, including PI3K/AKT/mTOR and MAPK, phosphorylate the protein [21].”
BackgroundThe HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation
Acuña-Pilarte, K., & Koh, M. Y. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2025.06.005 · Cited by 64
Metadata
- Authors
- Casillas, A. L., Chauhan, S. S., Toth, R. K., Sainz, A. G., Clements, A. N., Jensen, C. C., Langlais, P. R., Miranti, C. K., Cress, A. E., & Warfel, N. A.
- Affiliations
- University of Arizona (US)
- University of Arizona Cancer Center (US)
- Salk Institute for Biological Studies (US)
- Corresponding author
- Warfel, Noel A.
- ORCID
- Venue
- Oncogene
- Published
- 2021-07-02
- Volume
- 40
- Issue
- 32
- Pages
- 5142-5152
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- PMC
- PMC8364516
- OpenAlex
- W3176011664
- Cited by
- 44
- References
- 64
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 8 · 2023: 6 · 2022: 8 · 2021: 1
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (T32CA009213)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Keywords
- HIF-1α, PIM-1, protein stabilization, oxygen-dependent degradation domain, prolyl hydroxylase, HIF-2α, tumor angiogenesis, solid tumors, PIM inhibitors, tumor growth
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Animals, Disease Models, Animal, Humans, Mutation, Neoplasms, Neovascularization, Pathologic, Phosphorylation, Protein Binding, Gene Expression Regulation, Neoplastic, Cell Line, Tumor, Mice, Proto-Oncogene Proteins c-pim-1, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit, Protein Stability, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Direct phosphorylation and stabilization of HIF-1α by PIM1 kinase drives angiogenesis in solid tumors. https://app.cochat.ai/papers/10.1038/s41388-021-01915-1
- The paper
- Casillas, A. L., Chauhan, S. S., Toth, R. K., Sainz, A. G., Clements, A. N., Jensen, C. C., Langlais, P. R., Miranti, C. K., Cress, A. E., & Warfel, N. A. (2021). Direct phosphorylation and stabilization of HIF-1α by PIM1 kinase drives angiogenesis in solid tumors. Oncogene. https://doi.org/10.1038/s41388-021-01915-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.